Adverse events associated with aromatase inhibitors: An Analysis of Real-World Datasets and drug-gene interaction network

Aromatase inhibitors (AIs) are commonly used to treat postmenopausal hormone receptor positive breast cancer, but there is currently a lack of comprehensive safety reports on AIs in large-scale cohorts.